{"name":"Arrowhead Pharmaceuticals","slug":"arrowhead-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPUGg2VGk3aWxfc1pVMUR1ejJvcUFLa0lDYjVDRllwd2RUalRFVFBYTjNJUXJPMDVQLW91ZmdzR05DR01IQmoxakJOR3E4RER1RThpX2E4U2VRWmFPNGttR3NlODBwaUJPLVkzamtSNUxLQTR5WUV1aGgyQWx0eE9ka1NFNlJEWUdTaER6NE5UUl9IOWp0cHdR?oc=5","date":"2026-03-17","type":"pipeline","source":"Yahoo Finance","summary":"Arrowhead Pharmaceuticals Inc. (ARWR): Billionaire Ken Fisher Bets Big on Pharma - Yahoo Finance","headline":"Arrowhead Pharmaceuticals Inc. (ARWR): Billionaire Ken Fisher Bets Big on Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPcUFUcDVRT2w5N2ozS3ZzVG5XYWllVVJ6V0xpQXZKOE5BcGxuRGxFOHIxT2tOMS1lYnA5YThlVHhvUU80di1PTHYxMXlUanhKMU8tV1NSMWk0dHNxSkxMSUNRVG1uT2oxLXhGSlR6dDdhdUJ5WGNFOXQyZnhuT0hneGMzS2E2TktOV2lFSTR0aWVqbkdNOWsyRkNzZWpnenZGek9sbUY3Y0pOaTI2QmEtSlB3b3VxUEhNcHZaZkM3UEdQZ1J3WXd5SEhn?oc=5","date":"2026-02-24","type":"pipeline","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events - Arrowhead Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQZmsyVU0xYlVyZVA5dTZydWtvVjFpSHhOVkt3Yk90WHpZXzZ3ZEdsVXpZc0lVMlBEdjlTbXBMWGNQRG1GQVRGMThQa3QyZ09WelBRUnVST1YyamhJeUZrNWhrZHMwQzBwMmF0SFdVNmx5VG5yaDV1eWVOWlcyYThQLTYxRU4tcmRVNU9TRlJQWUFwWjNuVkRyOWNLNk90NEhhQlkwVDNqbjU4bUJXUWtELWs4M3JlTnIybC03QmpNZWNiOG8?oc=5","date":"2026-02-05","type":"earnings","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results - Arrowhead Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQbWJVRFl3eExXNEhqUHhudUFmYVJMbkg1TkpFQjNteUpENFllanlGRnZ5ZmZzUGNvNE1KQ1VmVmQ3VFlUMDhPOGphWW00VWFqM1hQY3lpcE9WMVUzbHlNbExncGtWRTVHNmZ5c0R2TUxGZzZmQW1xSk5WeWNhRkVMbUdMVEJ1OXMxYlBuVHVZYmdHZjFpTXoxcUZwb3pIT0VxcDVKcEFaY2poOXBZRmtmRmpfd3c2X05UV19mQkN6OTJnVzQ?oc=5","date":"2026-01-20","type":"earnings","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results - Arrowhead Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQR1AxY1V3WnItOTJaZEczWW1pT0dKbEQ4Wm8xdVUxNGo0aGZ0QWNWQ3JTam4za1diN2dSX2NJN0F4aDJPdDhaQTI5QS1KVjU4bGd1SGtnbjUtR21aNjRIM2hyc29zc3lHd0luUDU5VE1teVFHV0RhdmpJal91Q01PVzc5NTlRZTUzMzRkMUNrZ0kwdXBqbW5FaThxSnZNSkxiVEJ2TmM0NkV2MkROQ1lBQXJmVlFfR3VvbnlHdUl2a19Ucnd5SGY0?oc=5","date":"2026-01-07","type":"pipeline","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants - A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQNEhUckpnc3lQRTRocjk0UjQtYzFWNVRlWnEyVVY1eVIyRFFZNWJkQ3ZoMG11XzB2YUJCbEJVVVlsR2lsNjlFV3lPT3U2cHFrb3BzeVBlVU1Ca0pGQ1dYTmllV0NTWUxnY1BDOUNBQXdETE9MYXZlSUxyR2NfQVgzNUxNUU5CM0wyejlmLVZabTBhRHJsYmtKZjZBalBlTFNvRXBGdFJ3Qlc3a2gxd1VGRUVIUlV6c3JDZ3Z5Mw?oc=5","date":"2026-01-06","type":"pipeline","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock - Arrowhead Pharmace","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOX3NyZl80N09YRXc5QnlrdUQ4eTI3VmR1eGtWalR1Y0h0ZUd1bmNNMktBSmNSR184dDk0TnpoLXV3b1pta1U0T3pacFdMZE9zeGJubi1MVk0ydEFpaWxuc05ReUNRRXNlTU5tYUI3UzdQMjk5YVlUTTFkRHJnTndaNFFXbUxHeVNUNmtuYTBlN0psQi1wLWRJWldxUXFxWFU3ZWIxQlFkWE5TdVhhZjVYRHpoZ2tCdFQxV3ZJSVhyeFJuUkdRQWc?oc=5","date":"2025-12-02","type":"regulatory","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia - ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOYlp4Q3ZoSVRKaGdyWWNKSkhNRklKbEJQTmpBLUhJREdQNFhhMVB6N0s5WEFqMUVaZ1hGMi02cjZLM2lYMllwRUNUQTdOaWZuMkhydHp3R004b1diU1pRQU4zVU5wZVZCM1g4TEc2Qkh3SDBacGE0dXVXZzFUd1RHTFVzenJXR1VZSGpCTlowMmw5V2JGTVRIY3BSZEd3cTc0V0UtOEdFclRYbmNfTkF5VXpxM3Y0dnhac0RWc2l2WU52MGF3YkJF?oc=5","date":"2025-11-25","type":"earnings","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results - Arrowhead Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPTnVadEd6V0VHMDQ1dGcySFVnWXRMMHRyMnFfV2FvS3ZoM3pHbzJXNTJ4dG01b0psQ0lUbll2cDA3cHh4X25Lb3BrSmJFMEE2SG5GSXNMYWF1TzZmbzE5aWwzQ0ZXZzVZejlFTmxHNUQ0NWJzcm9xa1hNVEwxemVHZ2xYV2N2RUIwZjNIYWJ0YkpBNG5kMUN0RjdobEFBcHVUQlhVUWR6cGVkUUx2NTJ5eEdFZnRPYzkwN0h4UzdRQjBUVERvZ2c?oc=5","date":"2025-11-24","type":"pipeline","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics - Arrowhead Pharmaceuticals, In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQSWVLdWFYdnNJTEt3enUxeUZVZFJIQndzd3J1VGxxR3MzSHY2UXVsMkVnN2pkVmVhOWJHSnB4UmJ0Qjc5QVBHX25wa0UzQ3RqNHZodnVSclB1aGdzeXNhLXJaY3FtN0VWOHBfU0lGZlpvNmExQTE5OW4zc3hfWHdiSWQzVmU5VzI4TkNaOWtlTHhpdHlhQVBvc256b0xuTTMyVUkxUVVWbndQMGYwRDhLUl9iOTZ0di1yT1AzSVVmYVNxQQ?oc=5","date":"2025-11-18","type":"regulatory","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Famili","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPV1FaaUxZcDBiX2hOWTBsMHVybV83Ym1IYUExRV9hLWJlal9xc2dqS1A3akxSV0dxdy1kUnpDeXRFcnVWQk5Da0FkNUxETzNWa252ZzFyRDlxT2p2b05ScWFiZk5SOExEY2tHakFYcUpiSDFuejJPc1I5NlFYOTE5eGNmRzFBUmh0YzlRa2ZWSTdJdFRlaWd5LUgwdWpINlAyRVpQdTgteUV0ZVVMY2N0Z3hkNl9uMHlEWjBHZ09UcDB2QWtW?oc=5","date":"2025-11-04","type":"pipeline","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences - Arrowhead Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQTzlGa25lX21OTnNMM3JDdlp3TDdRN0RCVDI1M3Z4aDc1UHdZaUg1d25abXV3RDBjN2ExaUFEaXRDLTQySU95aWVKLURwTjVvdUdJM3VOeGwyX3dYMG40R3YzQzE3RkttVWdlZHNjV3JyRzREZXBYYmNqMTVLMnBXZ0pVRWZrV1dQcnVNTFhSNEljSHM5dkhyeXhTRGx4TWRILWdTejNlcVNZMkJfb0F6Q3daWS1NMmpJOU9oWEluN1ZlUHVGV1hwc3VR?oc=5","date":"2025-10-21","type":"deal","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis - Arrowhead Phar","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}